
Thermo Fisher Scientific reported Q2 profit and revenue that beat Wall Street estimates, with improving customer demand lifting sales across all business segments. The broad-based strength suggests improving end-market activity and supports a constructive near-term outlook.
Thermo Fisher Scientific reported Q2 profit and revenue that beat Wall Street estimates, with improving customer demand lifting sales across all business segments. The broad-based strength suggests improving end-market activity and supports a constructive near-term outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment